Combretum adenogonium
Combretum adenogonium · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Combretum adenogonium is a versatile botanical species known for its significant medicinal potential in various therapeutic applications. The leaves and stems of this plant serve as primary sources for various preparations, including methanolic, chloromethylenic, and alkaloid leaf extracts. Research has highlighted its potent antiviral activities, particularly in targeting the Herpes Simplex Virus Type 1. Furthermore, the presence of specific chemical compounds like Combretin A suggests its efficacy in addressing complex conditions such as Breast Cancer, Colitis, and Plasmodium falciparum. Through these diverse extracts, the plant continues to show promise in the development of modern pharmacological treatments.
- Synonyms
- Combretum Chevalieri · Combretum Reticulatum · 14 more
- Common names
- Not available
- Family
- Combretaceae
- Distribution
- Southern America
- Plant Parts
- Leaf · Stem
Classification
Common Names
Combretum adenogonium is a versatile species known by a diverse array of regional and descriptive names. Commonly referred to as the Four-Leaved Combretum or the four-leaved bushwillow, its identity is often tied to its distinct foliage. In various local contexts, the plant is also recognized by the names N'fiti and kakolo. Furthermore, it is frequently called the Ternate Combretum, adding to its rich linguistic variety. These multiple monikers highlight the plant's widespread presence and cultural significance across different landscapes.
Sources: Catalogue of Life (COL)
Synonyms
Combretum adenogonium is a complex botanical subject that has historically been classified under several different names. Throughout various taxonomic studies, this species has been identified by numerous synonyms, including Combretum albidiflorum and Combretum augustinum. Researchers have also documented its relationship to Combretum basarense and Combretum chevalieri in different scientific contexts. Furthermore, the name Combretum dalzielii has been used to describe specimens that are now recognized as part of this single species. Understanding these shifting nomenclatural relationships is essential for maintaining accuracy in modern plant identification.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Combretum adenogonium is a distinctive member of the kingdom Plantae. This species belongs to the diverse family Combretaceae, showcasing its unique evolutionary lineage. Within this family, it is classified under the order Myrtales, which links it to various other significant plant groups. It is further defined by its placement in the genus Combretum, a group known for its specific morphological traits. Ultimately, this plant is categorized under the class Equisetopsida, solid even within the broader botanical spectrum.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Myrtales |
| Family | Combretaceae |
| Genus | Combretum |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Combretum adenogonium is a resilient plant species widely distributed across various regions of the African continent. It is commonly found throughout East Tropical Africa, spanning through countries such as Kenya, Tanzania, and Uganda. Beyond the eastern coast, its presence extends into the Northeast Tropical Africa region. Specifically, the species can be identified within the borders of Chad and Eritrea. This broad geographic range highlights the plant's adaptability to diverse African landscapes.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Combretum adenogonium is a distinctively self-supporting species that takes the form of a sturdy tree. This botanical specimen displays a versatile range of dimensions, with heights starting as low as 3 meters. As the plant matures, it typically reaches a significant stature between 11 and 12 meters. Such structural diversity allows it to occupy various niches within its natural habitat. Ultimately, its robust growth form makes it a prominent feature of its ecosystem.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Combretum adenogonium has demonstrated significant potential in recent pharmacological screenings conducted in the Bunda district of Tanzania. This specific plant was identified as one of the key species exhibiting strong antiviral activity during laboratory testing. Specifically, extracts from this species showed remarkable efficacy against the Herpes Simplex Virus type 1. These results are characterized by high RF values, indicating a potent inhibitory effect at various concentrations. Such findings provide scientific validation for the traditional medicinal uses of the plant in treating infectious diseases.
Compounds
Combretum adenogonium is a plant species that contains the bioactive compound Combretin A. Scientific research highlights that Combretin A is a cycloartane-type triterpene known for its significant therapeutic potential. Studies indicate that this compound exhibits powerful anti-inflammatory, antioxidant, and anti-nociceptive activities. Furthermore, Combretin A has demonstrated promising anticancer properties, particularly in its ability to decrease the viability of MCF-7 breast cancer cell lines. These findings suggest that the chemical constituents found within the Combretum genus could serve as vital agents in treating inflammatory diseases and various forms of cancer.
Conditions
Combretum adenogonium demonstrates significant medicinal potential through its ability to treat Plasmodium falciparum. Research shows that extracts from this plant are also effective in treating HIV-1 (IIIB strain). Furthermore, the plant exhibits strong antiviral activity against Herpes Simplex Virus type 1. In addition to its antiviral properties, Combretum adenogonium has been shown to treat Clostridium chauvoei (jakari strain) neuraminidase activity. Finally, the plant's therapeutic profile includes the ability to treat acetic acid-induced pain.
Preparations
Combretum adenogonium is prepared as various types of extracts to facilitate medicinal screening. Specifically, the plant is processed into an alkaloid leaf extract for study. It is also prepared as chloromethylenic extracts and methanolic extracts. Furthermore, the species is utilized as methanolic extracts of the stem barks.
Parts used
Combretum adenogonium is a medicinal plant that shows significant pharmacological promise in the treatment of infectious diseases. Research conducted in Tanzania indicates that the leaves of this species possess notable antiplasmodial activity against Plasmodium falciparum. Furthermore, the plant's therapeutic potential extends to fighting HIV-1, with extracts derived from both its leaves and stem bark demonstrating effective inhibition. These findings highlight the importance of the different plant parts, specifically the leaf and stem, in providing bioactive compounds. Consequently, Combretum adenogonium remains a valuable subject for further investigation into natural antiviral and antimalarial treatments.